XT Investments

Venture Capital Active Israel
Last updated 2026-06-18
Portfolio
2
in our dataset
Rounds participated
2
Rounds led
0
Rounds' value
$398.0M
total disclosed, rounds participated
Stages

Portfolio · 2

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences1
Cyber Security1

Q&A

What is XT Investments' most significant exit?
XT Investments achieved a significant exit in March 2020 with the acquisition of Checkmarx by Hellman & Friedman for $1.15 billion.
Which sectors does XT Investments focus on?
XT Investments has shown a focus on the Health Tech & Life Sciences and Cyber Security sectors, with portfolio companies in both.
Can you name some of XT Investments' notable portfolio companies?
XT Investments' portfolio includes Angioslide, which develops embolic capture angioplasty devices, and Checkmarx, a cloud-native AppSec platform that was acquired in 2020.
What is the typical investment range for XT Investments?
XT Investments typically invests in the range of $3 million to $8.25 million.
When did XT Investments make its most recent investment according to available data?
XT Investments made an investment in May 2015, which was a D Round.
What funding stages has XT Investments participated in?
XT Investments has participated in various funding stages, including B Round, C Round, D Round, and E Round.